Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / SNY - International Wide-Moat Stocks On Sale - The December 2023 Heat Map


SNY - International Wide-Moat Stocks On Sale - The December 2023 Heat Map

2023-12-05 22:50:05 ET

Summary

  • Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating).
  • We are only interested in those targets that are attractively valued in historical comparison.
  • We share the heat map of the most investable candidates that may be worth your time for further analysis.

Step One: Wide-moat stocks with 5-star and 4-star ratings

Historical evidence says that while quality alone is a poor indicator of outperformance when combined with a decent valuation filter, Morningstar's moat rating proves to be more than useful. Based on the available data, stocks with a wide-moat rating that also fit into the 4- or 5-star category deserve to be the subject of further analysis. See the detailed explanation and the underlying evidence of our first step in this article .

We focus on those companies that are covered by a Morningstar analyst as assigning a wide-moat rating without thorough analysis is a questionable practice in our opinion. As of December 5, there were 79 international wide-moat stocks meeting our criteria (down from 80 a month ago, as Bayer AG was downgraded to narrow-moat).

Only 12.7% (10 stocks) of this wide-moat group earned a 5-star (most attractive) valuation rating. Here are they:

Company Name

Ticker

Barry Callebaut AG

OTCPK:BYCBF

British American Tobacco

BTI

GSK

GSK

Imperial Brands

OTCQX:IMBBY

Roche Holding AG

OTCQX:RHHBY

Tencent Holdings

OTCPK:TCEHY

Yum China Holdings

YUMC

ASX Ltd.

OTCPK:ASXFF

Alibaba Group Holding

BABA

Taiwan Semiconductor Manufacturing

TSM

We believe that the percentage of 5-star-rated wide-moat stocks is a good indicator of market sentiment. When this percentage is high, even the best companies are on sale. When the percentage is extremely low, market conditions may warrant caution. (Please note that this is not an indicator of market timing!)

Data from Morningstar. Dataset after 12/2022 only contains international stocks.

As these best-of-breed companies may be worth a closer look even when they are just slightly cheaper than their fair value but are not in the bargain bin, we also list the 4-star-rated wide-moat stocks as of December 5:

Company Name

Ticker

Anheuser-Busch InBev SA/NV

BUD

Adyen

OTCPK:ADYEY

Medtronic

MDT

Baidu

BIDU

Edenred

OTC:EDNMF

JD.com

JD

Harmonic Drive Systems

OTC:HSYDF

Spirax-Sarco Engineering

OTCPK:SPXSF

Sartorius Stedim Biotech

OTCPK:SDMHF

MTU Aero Engines AG

OTCPK:MTUAF

Airbus SE

OTCPK:EADSY

Allegion

ALLE

Ambev SA

ABEV

Assa Abloy AB

OTCPK:ASAZY

Daifuku

OTCPK:DFKCY

Experian

OTCQX:EXPGF

Fanuc

OTCPK:FANUY

GEA Group

OTCPK:GEAGF

Kao

OTCPK:KAOOY

KONE Oyj

OTCPK:KNYJF

Nabtesco

OTCPK:NCTKY

Nestle

OTCPK:NSRGY

OMRON

OTCPK:OMRNY

Reckitt Benckiser Group

OTCPK:RBGPF

Safran

OTCPK:SAFRF

Sanofi

SNY

Schindler Holding AG

OTCPK:SHLAF

Singapore Exchange

OTCPK:SPXCY

The Toronto-Dominion Bank

TD

Unilever

UL

Compagnie Financiere Richemont

OTCPK:CFRHF

Pernod Ricard

OTCPK:PDRDF

AstraZeneca

AZN

Novozymes A/S

OTCPK:NVZMF

BAE Systems

OTCPK:BAESY

Hoshizaki

OTCPK:HSHZY

All in all, we have 46 firms that pass our very first criteria.

Data from Morningstar. Dataset after 12/2022 only contains international stocks.

Step Two: Historical Valuation in the EVA Framework

We believe that the most widely used valuation multiples are terribly flawed. See this article on why we consider the Future Growth Reliance metric the best-of-breed sentiment indicator that addresses accounting distortions, thus giving us a true picture of which wide-moat companies seem attractively valued in historical terms. We want to buy our top-quality targets when the baked-in expectations are low since that is when surprising on the upside has the highest probability. As investment is a game of probabilities, all we can do is stack the odds in our favor as much as possible.

14 of the 46 stocks survived this second step . Here's the list:

Company Name

Ticker

Adyen

OTCPK:ADYEY

Allegion

ALLE

Ambev

ABEV

Baidu

BIDU

Barry Callebaut

OTCPK:BYCBF

Compagnie Financiere Richemont

OTCPK:CFRHF

GEA Group

OTCPK:GEAGF

GSK

GSK

JD.com

JD

Pernod Ricard

OTCPK:PDRDF

Roche Holding

OTCQX:RHHBY

Safran

OTCPK:SAFRF

Sanofi

SNY

Yum China Holdings

YUMC

We are rather strict when it comes to historical valuation. There are stocks that unquestionably fail both our short- and long-term tests. There are some targets, however, that may look attractively valued if you only focus on the short-term (like the last 5 years), but the longer you zoom out, the more you lose your appetite. It comes down to personal preference where you draw the line. For us, only those stocks are allowed to appear on the heat map in our third step that seems attractively valued in both a short-term and long-term context. (We go back as far as 20 years, calculate averages and medians on different time frames, and let our algorithm do the ruthless work.)

Step Three: The Heat Map of the most investable wide-moat stocks

Seeing the stocks of our shortlist on a heat map with a quality and valuation axis is something that can prove very useful when we need to make a decision on which candidates to analyze thoroughly. As explained in our previous article, we use the PRVit (Performance-Risk-Valuation investment technology) model of the EVA Dimensions team.

All in all, PRVit is a multifactor quantitative stock selection model based on EVA-centric measures of Performance, Risk, and Valuation. It first estimates the fundamental value of a company based on its risk-adjusted EVA performance (shown on the vertical axis) and then compares it to its actual valuation (shown on the horizontal axis). All factors in this model were chosen heuristically based on common sense, and not by data mining, yet strong and statistically significant backtests prove the soundness of the PRVit approach both in the U.S. and globally. ( See the details here .)

Here is the heat map as of December 5:

Institutional Shareholder Services Inc.

We also present the results in a table format to make your decision easier.

Institutional Shareholder Services Inc., Morningstar

(Stocks highlighted in light blue are Morningstar's 5-star-rated international wide-moat names that survived the second step of our process.)

In PRVit, the factors are grouped into three categories: Performance, Risk, and Valuation. Each company has a composite 0-100 score in each category, where higher is better for Performance and lower is better for Risk and Valuation. We believe stocks that have a 5-star Morningstar rating and/or finish in the upper quintile of the PRVit ranking (with a PRVit score above 80) are worth a closer look.

We plan to run this three-step process on a monthly basis and publish the shortlist of targets it produces.

For further details see:

International Wide-Moat Stocks On Sale - The December 2023 Heat Map
Stock Information

Company Name: Sanofi
Stock Symbol: SNY
Market: NASDAQ
Website: sanofi.com

Menu

SNY SNY Quote SNY Short SNY News SNY Articles SNY Message Board
Get SNY Alerts

News, Short Squeeze, Breakout and More Instantly...